Chartwell Investment Partners, LLC Heron Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 29, 2019	SELL	$16.36 - $21.39 $1.64 Million - $2.14 Million	-100,171 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$16.93 - $26.22 $19,113 - $29,602	1,129 Added 1.14%	100,171 $1.86 Million
Q1 2019 Apr 11, 2019	BUY	$23.15 - $28.34 $1.14 Million - $1.39 Million	49,160 Added 98.55%	99,042 $2.42 Million
Q4 2018 Feb 01, 2019	SELL	$22.03 - $32.01 $884,879 - $1.29 Million	-40,167 Reduced 44.61%	49,882 $1.29 Million
Q3 2018 Nov 08, 2018	BUY	$30.0 - $40.85 $894,360 - $1.22 Million	29,812 Added 49.49%	90,049 $2.85 Million
Q2 2018 Aug 09, 2018	SELL	$26.4 - $42.0 $3.74 Million - $5.95 Million	-141,740 Reduced 70.18%	60,237 $2.34 Million
Q1 2018 May 08, 2018	BUY	$18.43 - $28.8 $2.49 Million - $3.89 Million	135,022 Added 201.66%	201,977 $3.66 Million
Q1 2018 May 08, 2018	SELL	$18.43 - $28.8 $2.49 Million - $3.89 Million	-135,022 Reduced 66.85%	66,955 $1.85 Million
Q4 2017 Feb 08, 2018	BUY	$14.8 - $18.85 $844,044 - $1.08 Million	57,030 Added 39.35%	201,977 $3.66 Million
Q3 2017 Nov 08, 2017	BUY	$14.65 - $16.85 $2.12 Million - $2.44 Million	144,947	144,947 $2.34 Million

184

125M

847K

47.7K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $226M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.